Herrinton LJ - Search Results

1

Development of an algorithm to detect methotrexate wrong frequency error using computerized health care data.

Herrinton LJ, Woodworth TS, Eworuke E, Amsden LB, Liu L, Wyeth J, Petrone A, Menzin TJ, Williams J, Goldfien R, Nguyen M. Herrinton LJ, et al. Pharmacoepidemiol Drug Saf. 2019 Oct;28(10):1361-1368. doi: 10.1002/pds.4858. Epub 2019 Aug 13. Pharmacoepidemiol Drug Saf. 2019. PMID: 31410932

2

Variations in hospice use among cancer patients.

Keating NL, Herrinton LJ, Zaslavsky AM, Liu L, Ayanian JZ. Keating NL, et al. Among authors: herrinton lj. J Natl Cancer Inst. 2006 Aug 2;98(15):1053-9. doi: 10.1093/jnci/djj298. J Natl Cancer Inst. 2006. PMID: 16882942

3

Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings.

Herrinton LJ, Liu L, Lafata JE, Allison JE, Andrade SE, Korner EJ, Chan KA, Platt R, Hiatt D, O'Connor S. Herrinton LJ, et al. Inflamm Bowel Dis. 2007 Apr;13(4):451-61. doi: 10.1002/ibd.20021. Inflamm Bowel Dis. 2007. PMID: 17219403

4

Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization.

Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Weng X, et al. Among authors: herrinton lj. Am J Gastroenterol. 2007 Jul;102(7):1429-35. doi: 10.1111/j.1572-0241.2007.01215.x. Epub 2007 Apr 16. Am J Gastroenterol. 2007. PMID: 17437504

5

Early detection of adverse drug events within population-based health networks: application of sequential testing methods.

Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Brown JS, et al. Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1275-84. doi: 10.1002/pds.1509. Pharmacoepidemiol Drug Saf. 2007. PMID: 17955500

6

Mortality by medication use among patients with inflammatory bowel disease, 1996-2003.

Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ. Hutfless SM, et al. Among authors: herrinton lj. Gastroenterology. 2007 Dec;133(6):1779-86. doi: 10.1053/j.gastro.2007.09.022. Epub 2007 Sep 26. Gastroenterology. 2007. PMID: 18054550

7

Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease.

Altschuler A, Collins B, Lewis JD, Velayos F, Allison JE, Hutfless S, Liu L, Herrinton LJ. Altschuler A, et al. Among authors: herrinton lj. Inflamm Bowel Dis. 2008 Jul;14(7):992-9. doi: 10.1002/ibd.20416. Inflamm Bowel Dis. 2008. PMID: 18300277

8

Natural history of severe ulcerative colitis in a community-based health plan.

Allison J, Herrinton LJ, Liu L, Yu J, Lowder J. Allison J, et al. Among authors: herrinton lj. Clin Gastroenterol Hepatol. 2008 Sep;6(9):999-1003. doi: 10.1016/j.cgh.2008.05.022. Clin Gastroenterol Hepatol. 2008. PMID: 18774533

9

Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.

Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J. Herrinton LJ, et al. Am J Gastroenterol. 2008 Aug;103(8):1998-2006. doi: 10.1111/j.1572-0241.2008.01960.x. Am J Gastroenterol. 2008. PMID: 18796097

10

Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations.

Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Brown JS, et al. Pharmacoepidemiol Drug Saf. 2009 Mar;18(3):226-34. doi: 10.1002/pds.1706. Pharmacoepidemiol Drug Saf. 2009. PMID: 19148879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters